Psychiatric Medication Discontinuation/Reduction Study (PMDR)
The Psychiatric Medication Discontinuation/Reduction study (PMDR) is the first U.S. survey of a large sample of longer-term users who chose to discontinue psychiatric medications. The study, funded by the Foundation for Excellence in Mental Health Care and led by current and former users of psychiatric medications, sought to understand first-hand experiences and strategies of individuals who decided to discontinue psychiatric medications, and either stopped or reduced the use of these medications.
The experience of discontinuation itself was reported to be physically and emotionally challenging, with respondents reporting several undesirable withdrawal effects that have been noted in previous research. Nonetheless, 82% of respondents who achieved their medication goals reported being satisfied or very satisfied with their decision.
Live & Learn, Inc. is invested in promoting public access to the research process. The dataset for the Psychiatric Medication Discontinuation and Reduction Study is now freely available through Open ICPSR (Inter-university Consortium for Political and Social Research). A big thank you to the FEMHC for funding this data transparency effort and for everyone who participated in the study!
Psychosis journal article: “An exploratory analysis of the role of social supports in psychiatric medication discontinuation: results related to family involvement.” (May 2019)
Psychiatric Services journal article: “Discontinuing Psychiatric Medications: A Survey of Long-Term Users." (July 2017)
Blog post on initial findings (July 2017)
Background & Methods Report (December 2016)
Press & Media
Press Release (July 2017)
Presentations & Handouts
APHA 2017 Annual Meeting & Expo: "Social support among individuals discontinuing psychiatric medication" (November 2017)